$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| TAGRISSO APPROVED IN EU BASED ON LAURA TRIAL | 23 Dec 2024 |
| DIRECTORATE CHANGE | 16 Dec 2024 |
| IMFINZI APPROVED IN US FOR LIMITED-STAGE SCLC | 05 Dec 2024 |
| ASTRAZENECA APPOINTS ISKRA REIC EVP INTERNATIONAL | 04 Dec 2024 |
| BLOCK LISTING INTERIM REVIEW | 02 Dec 2024 |
| TOTAL VOTING RIGHTS | 02 Dec 2024 |
| TRUQAP IMPROVED RPFS IN ADVANCED PROSTATE CANCER | 25 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 20 Nov 2024 |
| TAGRISSO RECOMMENDED FOR EU APPROVAL - LAURA | 18 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 15 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 15 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 13 Nov 2024 |
| 9M AND Q3 2024 RESULTS | 12 Nov 2024 |
| KOMET PHASE III TRIAL MET PRIMARY ENDPOINT | 12 Nov 2024 |
| DATO-DXD NEW BLA SUBMITTED, NSQ BLA WITHDRAWN | 12 Nov 2024 |
| ASTRAZENECA INVESTS $3.5 BILLION IN US | 12 Nov 2024 |
| TEZSPIRE NASAL POLYPS TRIAL MET PRIMARY ENDPOINTS | 08 Nov 2024 |
| TOTAL VOTING RIGHTS | 01 Nov 2024 |
| AZN CHINA PRESIDENT UNDER INVESTIGATION | 30 Oct 2024 |
| SC 13G | 28 Oct 2024 |
